On Aug. ten, the FDA dominated to reject copyright for assisted psychotherapy for PTSD, citing insufficient evidence and the necessity for more analysis. The ruling is according to a letter APA sent the FDA before this calendar year that mentioned that an assessment with the literature on copyright-assisted psychotherapy by a multidisciplinary pane